The FDA has given Imatron the go-ahead to market and sell its electron-beam computed tomography (EBCT) scanner for colonography, the company said last week. The 510(k) was granted for the minimally invasive procedure that permits visualization of the
The FDA has given Imatron the go-ahead to market and sell its electron-beam computed tomography (EBCT) scanner for colonography, the company said last week. The 510(k) was granted for the minimally invasive procedure that permits visualization of the interior surface of the colon from a virtual "fly-through." Imatron's device is the only CT scanner specifically cleared for colonographic use. n
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Approves New PSMA PET Agent POSLUMA for Prostate Cancer Imaging
May 30th 2023Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum prostate-specific antigen (PSA) level.
2 Clarke Drive
Cranbury, NJ 08512